BEDFORD; Simon

Patent Applications and Registrations

Patent applications and USPTO patent grants for BEDFORD; Simon.The latest application filed is for "3,6-diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their uses as pro-apoptotic agents".

Company Profile

3.14.15

BEDFORD; Simon - Harlow GB
Bedford; Simon - Great Abington GB
Bedford; Simon - Winnersh GB
Bedford; Simon - Berkshire GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3,6-diamino-pyridazin-3-yl Derivatives, Pharmaceutical Compositions Containing Them And Their Uses As Pro-apoptotic Agents App 20220289734 - DAVIDSON; James Edward Paul ; et al.	2022-09-15
Thienopyrimidine compounds Grant 11,028,097 - Jordan , et al. June 8, 2	2021-06-08
Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory Activity App 20200361905 - Stokes; Stephen ; et al.	2020-11-19
Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity Grant 10,696,652 - Stokes , et al. June 30, 2	2020-06-30
Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them Grant 10,662,173 - Casara , et al.	2020-05-26
Thienopyrimidine Compounds App 20200140455 - Jordan; Allan ; et al.	2020-05-07
Thienopyrimidine compounds Grant 10,556,911 - Jordan , et al. Feb	2020-02-11
Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory Activity App 20180244652 - Stokes; Stephen ; et al.	2018-08-30
Thienopyrimidine Compounds App 20180162872 - Jordan; Allan ; et al.	2018-06-14
Thienopyrimidine compounds Grant 9,920,066 - Jordan , et al. March 20, 2	2018-03-20
Indole And Pyrrole Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20170342051 - CASARA; Patrick ; et al.	2017-11-30
Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory Activity App 20170298043 - Stokes; Stephen ; et al.	2017-10-19
Thienopyrimidine Compounds App 20170291907 - Jordan; Allan ; et al.	2017-10-12
Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them Grant 9,765,056 - Casara , et al. September 19, 2	2017-09-19
Thienopyrimidine compounds Grant 9,610,290 - Jordan , et al. April 4, 2	2017-04-04
Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity Grant 9,604,975 - Stokes , et al. March 28, 2	2017-03-28
Indole And Pyrrole Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20160152599 - CASARA; Patrick ; et al.	2016-06-02
Thienopyrimidine Compounds App 20150342953 - Jordan; Allan ; et al.	2015-12-03
Thienopyrimidine compounds Grant 9,120,807 - Jordan , et al. September 1, 2	2015-09-01
Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory Activity App 20150099736 - Stokes; Stephen ; et al.	2015-04-09
Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity Grant 8,916,591 - Stokes , et al. December 23, 2	2014-12-23
Thienopyrimidine compounds and compositions Grant 8,354,415 - Jordan , et al. January 15, 2	2013-01-15
Thienopyrimidine Compounds App 20110118284 - Jordan; Allan ; et al.	2011-05-19
Indolyl- Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory Activity App 20110021498 - Stokes; Stephen ; et al.	2011-01-27
Pyrrolopyrimidine Compounds App 20100305143 - Jordan; Allan ; et al.	2010-12-02
Thienopyrimidine Compounds And Compositions App 20100298349 - Jordan; Allan ; et al.	2010-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.